Evolus (EOLS) Releases Favorable Dermal Fillers Study Data

Evolus, Inc. (EOLS) has announced favorable results from its pivotal U.S. nasolabial fold (NLF) study of dermal filler products, Evolysse Lift and Smooth. Presented at the 2024 SCALE Meeting, these results represent a significant milestone in the company's strategic expansion within the aesthetic device market. These promising results bolster the company's upcoming Premarket Approval Application ("PMA") for the U.S. launch of Evolus's dermal filler lines. Evolus plans to submit the PMA applications for Evol ...